Alpha Tau Medical (DRTS) Operating Leases (2022 - 2026)

Alpha Tau Medical (DRTS) has 5 years of Operating Leases data on file, last reported at $6.7 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases rose 15.76% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (up 15.76% YoY), and the FY2025 full-year result was $6.2 million, up 4.68% from the prior year.
• Operating Leases grew to $6.7 million in Q1 2026, from $6.2 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $6.7 million in Q1 2026 to a low of $4.5 million in Q4 2022.
• A 5-year average of $5.9 million and a median of $6.1 million in 2024 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases jumped 45.98% in 2023 and dropped 9.69% in 2024, its largest moves.
• Tracing DRTS's Operating Leases over 5 years: stood at $4.5 million in 2022, then surged by 45.98% to $6.6 million in 2023, then retreated by 9.69% to $6.0 million in 2024, then advanced by 4.68% to $6.2 million in 2025, then grew by 7.91% to $6.7 million in 2026.
• Business Quant data shows DRTS's Operating Leases at $6.7 million in Q1 2026, $6.2 million in Q4 2025, and $6.2 million in Q3 2025.